agnes basseville
agnes basseville
research biologist, Institut de Cancérologie de l'Ouest
Verified email at
Cited by
Cited by
Targeting MDR in breast and lung cancer: discriminating its potential importance from the failure of drug resistance reversal studies
L Amiri-Kordestani, A Basseville, K Kurdziel, AT Fojo, SE Bates
Drug Resistance Updates 15 (1-2), 50-61, 2012
Histone deacetylase inhibitors: emerging mechanisms of resistance
RW Robey, AR Chakraborty, A Basseville, V Luchenko, J Bahr, Z Zhan, ...
Molecular pharmaceutics 8 (6), 2021-2031, 2011
Irinotecan induces steroid and xenobiotic receptor (SXR) signaling to detoxification pathway in colon cancer cells
A Basseville, L Preisser, S de Carné Trécesson, M Boisdron-Celle, ...
Molecular cancer 10, 1-12, 2011
Histone deacetylase inhibitors influence chemotherapy transport by modulating expression and trafficking of a common polymorphic variant of the ABCG2 efflux transporter
A Basseville, A Tamaki, C Ierano, S Trostel, Y Ward, RW Robey, ...
Cancer research 72 (14), 3642-3651, 2012
BCL-XL directly modulates RAS signalling to favour cancer cell stemness
S Carné Trécesson, F Souazé, A Basseville, AC Bernard, J Pécot, ...
Nature Communications 8 (1), 1123, 2017
Gout, genetics and ABC transporters
A Basseville, SE Bates
F1000 biology reports 3, 2011
Antitumor effect of pharmacologic ascorbate in the B16 murine melanoma model
OK Serrano, NL Parrow, PC Violet, J Yang, J Zornjak, A Basseville, ...
Free Radical Biology and Medicine 87, 193-203, 2015
The ABCG2 multidrug transporter
A Basseville, MD Hall, CH Chau, RW Robey, M Gottesman, WD Figg, ...
ABC transporters-40 years on, 195-226, 2016
Blocking downstream signaling pathways in the context of HDAC inhibition promotes apoptosis preferentially in cells harboring mutant Ras
JC Bahr, RW Robey, V Luchenko, A Basseville, AR Chakraborty, ...
Oncotarget 7 (43), 69804, 2016
Histone deacetylase inhibitors induce CXCR4 mRNA but antagonize CXCR4 migration
C Ierano, A Basseville, KKW To, Z Zhan, RW Robey, J Wilkerson, ...
Cancer Biology & Therapy 14 (2), 175-183, 2013
R-loop–mediated ssDNA breaks accumulate following short-term exposure to the HDAC inhibitor romidepsin
M Safari, T Litman, RW Robey, A Aguilera, AR Chakraborty, WC Reinhold, ...
Molecular Cancer Research 19 (8), 1361-1374, 2021
ABC transporters-40 years on
A Basseville, MD Hall, CH Chau, RW Robey, M Gottesman, WD Figg, ...
Springer International Publishing, Cham, 2016
Targeting KRAS and the vitamin D receptor via microtubules
A Basseville, S Bates, T Fojo
Nature Reviews Clinical Oncology 12 (8), 442-444, 2015
Breast cancer resistance protein (BCRP) or ABCG2
A Basseville, RW Robey, JC Bahr, SE Bates
Drug transporters: molecular characterization and role in drug disposition …, 2014
A Basseville, SE Bates, WD Figg, A Sparreboom
Pharmacogenomics of human drug transporters: Clinical impacts, 311-343, 2013
A histone deacetylase inhibitor induces acetyl-coA depletion leading to lethal metabolic stress in RAS-pathway activated cells
A Basseville, PC Violet, M Safari, C Sourbier, WM Linehan, RW Robey, ...
Cancers 14 (11), 2643, 2022
Targeting of MCL-1 in breast cancer-associated fibroblasts reverses their myofibroblastic phenotype and pro-invasive properties
TL Bonneaud, CC Lefebvre, L Nocquet, A Basseville, J Roul, H Weber, ...
Cell death & disease 13 (9), 787, 2022
Brain neural progenitors are new predictive biomarkers for breast cancer hormonotherapy
A Basseville, C Cordier, F Ben Azzouz, W Gouraud, H Lasla, F Panloup, ...
Cancer Research Communications 2 (8), 857-869, 2022
Interest of the bc-GenExMiner web tool in oncology
P Jezequel, W Gouraud, FB Azzouz, A Basseville, PP Juin, H Lasla, ...
Bulletin du Cancer 108 (11), 1057-1064, 2021
Characterization of the aggresome targeted Q141K ABCG2/BCRP variant.
A Basseville, S Shukla, A Tamaki, R Robey, SV Ambudkar, SE Bates
Cancer Research 73 (8_Supplement), 2193-2193, 2013
The system can't perform the operation now. Try again later.
Articles 1–20